| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |